Company Comparison
54gene vs AbCellera
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | 54gene | AbCellera |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Lagos, Nigeria | — |
| Founded | 2019 | — |
| Status | Active | Active |
| Last Funding Stage | Series B | — |
| Total Funding | $45M | — |
| Valuation | — | — |
What They Build
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
AbCellera
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics.
Key Investors
AbCellera
Sector Overlap
Both 54gene and AbCellera operate in Biotech.
Browse all Biotech companies →Websites
Sponsored
AArchstone
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees
Now in alpha with select funds. 14-day trial available.